| Literature DB >> 26337219 |
Alexandre R Vieira1, Moses Lee2, Filippo Vairo3, Julio Cesar Loguercio Leite4, Maria Cristina Munerato4, Fernanda Visioli4, Stéphanie Rodrigues D'Ávila4, Shih-Kai Wang5, Murim Choi6, James P Simmer5, Jan C-C Hu5.
Abstract
Hyperphosphatemic familial tumoral calcinosis (HFTC, OMIM #211900) is an autosomal recessive metabolic disorder characterized by hyperphosphatemia, tooth root defects, and the progressive deposition of calcium phosphate crystals in periarticular spaces, soft tissues, and sometimes bone.(1) In this HFTC case report, we document the dental phenotype associated with a homozygous missense mutation (g.29077 C>T; c.484 C>T; p.Arg162*) in GALNT3 (OMIM 6017563), a gene encoding UDP-GalNAc transferase 3 that catalyzes the first step of O-linked oligosaccharide biosynthesis in the Golgi. The medical and dental pathology is believed to be caused primarily by high serum phosphate levels (hyperphosphatemia), which, in turn, is caused by failure of GALNT3 to glycosylate the phosphate regulator protein FGF23, impairing its ability inhibit reabsorption of filtered phosphate in the kidneys.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26337219 PMCID: PMC4640955 DOI: 10.1016/j.oooo.2015.05.006
Source DB: PubMed Journal: Oral Surg Oral Med Oral Pathol Oral Radiol